FindTrial
Sign In

Effect of Amiodarone for preventing atrial fibrillation in cardiac surgery.

PROPHYLACTIC EFFECT OF AMIODARONE IN ATRIAL FIBRILLATION DURING CORONARY ARTERY BYPASS GRAFTING SURGERY: A RANDOMIZED CONTROLLED TRIAL.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030750
Enrollment
190
Registered
2021-01-25
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I20-I25- Ischemic heart diseases Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Amiodarone Group: 300 mg bolus dose of amiodarone diluted to 20 cc will be given over a period of 20 min to the patients at the time of induction of anesthesia followed by infusion of a

Sponsors

KIMSDU Karad
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Age from 18-60 years, Patients of both sex will be included. 2. Patient electively posted for CABG.

Exclusion criteria

Exclusion criteria: 1. Allergic reaction to antiarrhythmic drugs. 2. Emergencies operations. 3. Pregnancy. 4. Redo surgery. 5. Patient Refusal. 6. Hypothyroid patients. 7. Patients who have preoperative arrhythmias. 8. Patients requiring more than 4 coronary artery bypass grafts.

Design outcomes

Primary

MeasureTime frame
Amiodarone helps to prevent atrial fibrillation in cardiac surgical patietnts as compared to placebo represented by p value of less than 0.05Timepoint: 6 months—

Secondary

MeasureTime frame
Cost of therapy Prevention of other complications Hemodynamic ChangesTimepoint: 6 months—

Countries

India

Contacts

Public ContactDr Samrat Sukumar Madanaik

Krishna Institute of Medical University deemed to be University

samratmadanaik@gmail.com9686998590

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026